Renergen Ltd RGNNF

$0.56 -0.01 (-1.30%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
2,000
Avg volume
17,484
Day's range
$0.56 – $0.56
Shares out
—
Stochastic %K
91%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electri...

Show more

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 7, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc.

Industry
Oil & Gas E&P
Sector
Energy
Website
https://www.renergen.co.za
Address
Sandton Gate, Second Floor 25 Minerva Ave Glenadrienne, Sandton, South Africa

Latest news

No headlines yet.